A team of scientists has identified the specific genes that aggravate or delay the onset of high-grade serious ovarian carcinoma. The findings will help to identify women at risk of developing ovarian cancer besides paving the way for finding new therapies targeting the specific genes.
The study that was conducted by a team of scientists from the Cornell University College of Veterinary Medicine was published Sept. 1 in Cell Reports. High-grade serious ovarian carcinoma (HGSOC) was the fifth-leading cause of cancer-related deaths in women in the United States. Yet, little was known about the origins of this disease. The study’s senior author, John Schimenti, professor of genetics in the Department of Biomedical Sciences, stated:
“We’ve taken the enormous collection of genomic mutation data that’s been mined on cancer genetics and tried to make functional sense of it.”
Read the original article on Liquid Health News here
